Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases.
Jean-François KorobelnikPaolo LanzettaCharles C WykoffTien-Yin WongXin ZhangPeter Morgan-WarrenScott FitzpatrickSergio LealLynne BrunckZoran HasanbasicKaren W ChuKimberly ReedSobha SivaprasadPublished in: Eye (London, England) (2024)